Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA.
J Immigr Minor Health. 2012 Oct;14(5):754-8. doi: 10.1007/s10903-012-9577-7.
Breast cancer prognosis and breast cancer molecular subtype vary by race/ethnicity. We determined whether the distribution of breast cancer subtypes varies among different Asian ethnic groups. Using immunohistochemical surrogates for the four molecularly defined breast cancer subtypes, we characterized breast cancer subtype for 346 Asian subjects treated at two New York City institutions. We found that Chinese and Japanese had a higher proportion of good-prognosis luminal A cancers (66.7 and 80.0%, respectively) compared to Filipinos and Koreans (48.5 and 47.1%) (P = 0.001). Filipinos had a higher proportion of HER-2/neu positive cancers (45.6%) compared to other ethnic groups (23.6%) (P = 0.002).Koreans had a higher proportion of triple negative cancers(23.5%) compared to other ethnic groups (7.5%) (P =0.06). The results suggest that differences exist in breast cancer tumor biology among distinct Asian ethnic groups and have implications for cancer care and research. Future studies of breast cancer in Asian-Americans should distinguish among the different ethnic groups.
乳腺癌的预后和分子亚型因种族/民族而异。我们确定了不同亚裔族群之间乳腺癌亚型的分布是否存在差异。使用四种分子定义的乳腺癌亚型的免疫组织化学替代物,我们对在纽约市两家机构接受治疗的 346 名亚裔患者的乳腺癌亚型进行了特征描述。我们发现,与菲律宾人和韩国人相比,中国人和日本人具有更高比例的预后良好的 luminal A 型癌症(分别为 66.7%和 80.0%)(P = 0.001)。与其他族群(23.6%)相比,菲律宾人具有更高比例的 HER-2/neu 阳性癌症(45.6%)(P = 0.002)。与其他族群(7.5%)相比,韩国人具有更高比例的三阴性癌症(23.5%)(P = 0.06)。这些结果表明,不同亚裔族群之间的乳腺癌肿瘤生物学存在差异,这对癌症的治疗和研究具有重要意义。未来对亚裔美国人的乳腺癌研究应区分不同的族群。